Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZC71
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,587
Award facts
- Contract value 100% obligated
- $2,587.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. This firm fixed-price delivery order was issued on September 5, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. No set-aside designation was used for this procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has served as a critical supplier in the federal pharmaceutical supply chain since its registration in the System for Award Management in 2001. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to Department of Defense healthcare facilities. Through its master contract with the Defense Logistics Agency under the SPE2DB program, DMS Pharmaceutical Group has established a robust portfolio of delivery orders covering an extensive array of medical products, including specialty pharmaceuticals such as Botox, oncology treatments, vaccines, and other injectable medications essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FZC71?
SPE2DB25FZC71 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FZC71 worth?
The government has obligated $2,587 on SPE2DB25FZC71.
Is contract SPE2DB25FZC71 an order under another contract?
Yes. SPE2DB25FZC71 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC71 competed?
The extent of competition for SPE2DB25FZC71 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award